文献速递腹部技术与安全PETMRCT

18F-FDG PET/MR与PET/CT在肝门部胆管癌治疗前TNM分期中的比较

Comparison of 18F-FDG PET/MR and PET/CT for pretreatment TNM staging of hilar cholangiocarcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2023-05-13

回顾性分析58例经病理证实的肝门部胆管癌患者,先行18F-FDG PET/CT再行全身PET/MR。PET/MR诊断T分期和N分期的准确率显著高于PET/CT(72.4% vs. 58.6%,P=0.022;84.5% vs. 67.2%,P=0.002),Bismuth-Corlette分型准确率亦显著更高(89.7% vs. 79.3%,P=0.031);M分期两组无显著差异(94.8% vs. 98.3%,P=0.5)。

要点

  • PET/MR对肝门部胆管癌T分期准确率72.4%,高于PET/CT的58.6%(P=0.022)。
  • PET/MR对N分期准确率84.5%,高于PET/CT的67.2%(P=0.002)。
  • PET/MR对Bismuth-Corlette分型准确率89.7%,高于PET/CT的79.3%(P=0.031)。

核心结论

  • 18F-FDG PET/MR在肝门部胆管癌治疗前T分期、N分期及Bismuth-Corlette分型方面的诊断准确率优于PET/CT;在M分期方面,PET/MR的诊断准确率与PET/CT相似。

研究设计与样本

  • 回顾性分析58例经病理证实的肝门部胆管癌患者,先行18F-FDG PET/CT显像,随后行全身PET/MR显像,测量肿瘤及正常肝组织的SUVmax。

诊断标准与关键数值

  • 原发肿瘤病灶SUVmax:PET/CT为6.6 ± 5.5,PET/MR为6.8 ± 6.2,两者无显著差异(P = 0.439)。
  • 正常肝实质SUVmax:PET/CT为3.0 ± 0.5,PET/MR为2.1 ± 0.5,两者有显著差异(P < 0.001)。
  • T分期诊断准确率:PET/MR为72.4%,PET/CT为58.6%(P = 0.022)。
  • N分期诊断准确率:PET/MR为84.5%,PET/CT为67.2%(P = 0.002)。
  • M分期诊断准确率:PET/CT为94.8%,PET/MR为98.3%(P = 0.5),两者无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: 18F-FDG PET/MR has been applied to the diagnosis and preoperative staging in various tumor types; however, reports using PET/MR in hilar cholangiocarcinoma (HCCA) are rare. We investigated the value of PET/MR for preoperative staging and compared it with PET/CT in HCCA.

METHODS: Fifty-eight patients with HCCA confirmed by pathology were retrospectively analyzed. 18F-FDG PET/CT imaging was performed first, followed with whole-body PET/MR imaging. SUVmax of tumor and normal liver tissue were measured. Paired T test was used to compare SUVmax of tumor and normal liver tissue of PET/CT and PET/MR. In addition, McNemar test was used to compare the accuracy of TNM staging and Bismuth-Corlette typing between PET/CT and PET/MR.

RESULTS: There was no significant difference in SUVmax between PET/CT and PET/MR in primary tumor lesions (6.6 ± 5.5 vs. 6.8 ± 6.2, P = 0.439). SUVmax of PET/CT and PET/MR in normal liver parenchyma was significantly different (3.0 ± 0.5 vs. 2.1 ± 0.5, P < 0.001). The accuracy of PET/MR in diagnosing T staging and N staging was significantly higher than those of PET/CT (72.4% vs. 58.6%, P = 0.022 and 84.5% vs. 67.2%, P = 0.002). There was no significant difference between PET/CT and PET/MR in M staging (94.8% vs. 98.3%, P = 0.5). The classification accuracy of PET/MR in Bismuth-Corlette was significantly higher than that of PET/CT (89.7% vs. 79.3%), P = 0.031.

CONCLUSIONS: The diagnostic accuracy of 18F-FDG PET/MR was superior to that of PET/CT in preoperative T staging, N staging, and Bismuth-Corlette classification of HCCA. In M staging, the diagnostic accuracy of PET/MR was similar to that of PET/CT.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Pang, Mao, Zhang, et al. Comparison of 18F-FDG PET/MR and PET/CT for pretreatment TNM staging of hilar cholangiocarcinoma. Abdom Radiol (NY). 2023. PMID: 37179282. doi:10.1007/s00261-023-03925-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。